Hormonal regulation of apoptosis and the Fas and Fas ligand system in human endometrial cells

Molecular Human Reproduction

Volumn 8, Issue 5, 2002, Pages 447-455

  Song, Joon ^a   Rutherford, Thomas ^a   Naftolin, Frederick ^a   Brown, Santiago ^a   Mor, Gil ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Endometrium; Estrogen; Fas; Progesterone

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ESTROGEN; FAS ANTIGEN; FAS LIGAND; PROGESTERONE; PROPIDIUM IODIDE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENDOMETRIUM CELL; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; PRIORITY JOURNAL; WESTERN BLOTTING;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; CELLS, CULTURED; ENDOMETRIUM; ESTRADIOL; FEMALE; HORMONES; HUMANS; PROGESTERONE; STROMAL CELLS;

EID: 0036262730     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/8.5.447     Document Type: Article

References (32)

1. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain
2. Progestin regulation of cellular proliferation
3. Apoptosis, proliferation and sex hormone receptors in superficial parts of human endometrium at the end of the secretory phase
4. Endometrial microstructure: Structure-function relationship throughout the menstrual cycle
5. Fas ligand expression is restricted to nonlymphoid thymic components in situ
6. P53-dependent DNA damage-induced apoptosis requires Fas/Apo-1-independent activation of Cpp32-beta
7. Macrophage-derived growth factors regulate FasL expression in endometrial stromal cells
8. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
9. The Fas/Fas-Ligand system: A mechanism for immune evasion in human breast carcinomas
10. Apoptosis in the human uterine endometrium during the menstrual cycle
11. Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c
12. Advanced ovarian carcinoma: Molecular evidence of unifocal origin
13. Fas-Fas ligand system induced apoptosis in human placenta and gestational trophoblastic disease
14. Macrophages, estrogen and the microenvironment of breast cancer
15. Regulation of Fas ligand expression in breast cancer cells by estrogen: Functional differences between estradiol and tamoxifen
16. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
17. Fas and Fas ligand: A death factor and its receptor
18. Progesterone withdrawal up-regulates vascular endothelial growth factor receptor type 2 in the superficial zone stroma of the human and macaque endometrium: Potential relevance to menstruation
19. Human lung carcinomas express Fas ligand
20. Dating the endometrial biopsy
21. Lethal effect of the anti-Fas antibody in mice
22. Bcl-2 inhibits retinoic acid-induced apoptosis during the neural differentiation of embryonal stem cells
23. Cyclic bcl-2 gene expression in human uterine endometrium during menstrual cycle
24. Serum deprivation-induced apoptosis in cultured porcine granulosa cells is characterized by increased expression of p53 protein, Fas antigen and Fas ligand and by decreased expression of PCNA
25. Perturbation of the mitosis/apoptosis balance - A fundamental mechanism in toxicology
26. Characterization of uterine epithelium apoptotic cell death kinetics and regulation by progesterone and RU 486
27. Matrix metalloproteinase expression in Macaca mulatta endometrium: Evidence for zone-specific regulatory tissue gradients
28. Regulation of Fas ligand expression by estrogen in normal ovary
29. Effects of keratinocyte growth factor in the endometrium of Rhesus macaques during the luteal-follicular transition
30. Expression of Fas and Fas ligand during pregnancy, lactation and involution and its potential role during mammary gland remodeling
31. Membrane Fas ligand kills human peripheral blood T lymphocytes and soluble Fas ligand blocks the killing
32. Fas ligand, Fas antigen and Bcl-2 expression in human endometrium during the menstrual cycle